Analysts predict that Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Rating) will announce sales of $99.13 million for the current quarter, according to Zacks. Two analysts have made estimates for Corcept Therapeutics’ earnings. The lowest sales estimate is $96.20 million and the highest is $102.05 million. Corcept Therapeutics posted sales of $79.44 million in the same […]
